Sarin KC is Head of the Environmental Economics Unit at HITAP, Ministry of Public Health, Thailand. Previously, he worked as a research analyst at the London School of Economics and Political Science (LSE) and the Ministry of Health and Population in Nepal.As a health economist, he has helped institutionalise Health Technology Assessment (HTA) in c

Apirujee Punjataewakupt, PhD, earned her doctoral degree in pharmaceutical sciences from Chulalongkorn University. She has diverse experience in both the pharmaceutical industry and health-related research. She is currently serving as a research assistant at the Health Intervention and Technology Assessment Program (HITAP).Her expertise includes ph

Siobhan has spent over 10 years working in public health at the national, regional, and global level, with experience across health technology assessment, market shaping, vaccine implementation, and capacity building in Asia, Africa, and the Americas. She has led studies employing a variety of methodologies, including system dynamics, qualitative c

Panupong Chaowanasawat is an Associate at the Health Intervention and Technology Assessment Program (HITAP). He holds a Bachelor of Science in Public Health (Honors) with a minor in Global Health and Social Medicine from Wayne State University, USA. His academic and professional background reflects a strong commitment to public health research and

Zin is an Associate at the International Unit of the Health Intervention and Technology Assessment Program (HITAP) Foundation. She specializes in Health Technology Assessment (HTA) to inform decision making in health policy through country-focused initiatives. Zin received her Bachelor in Pharmacy from University of Pharmacy (Yangon) and completed

Saudamini Dabak is the Head of HITAP’s International Unit (HIU). She started working at HITAP as an Overseas Development Institute (ODI) Fellow in 2015. At HITAP, Saudamini has supported Health Technology Assessment (HTA) initiatives in Asia and Africa and has also been involved in conducting health systems research. Prior to working at HITAP, Saud

Parntip Juntama is a Researcher at HITAP specializing in Health Technology Assessment (HTA) and Health Economics. Her work focuses on policy-related research that provides evidence to support healthcare policy decisions in Thailand.Research Focus:Parntip conducts research on various health policy topics to inform national public health strategies.

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.

Kidney failure (KF)[1] is a life-threatening disease that requires either kidney transplantation or dialysis for survival (1, 2). As of 2019, it was estimated that globally, 1.4 million deaths occurred on account of chronic kidney disease (CKD) (3). The cost of treatment for KF is also high, leading to catastrophic household expenditure to househo

66261068HM025L0Early Health Technology Assessment,pulmonary tuberculosis